200,000+ products from a single source!
sales@angenechem.com
219311-44-1 | N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide
CAS No: 219311-44-1 Catalog No: AG0034OM MDL No:
Product Description
Catalog Number:
AG0034OM
Chemical Name:
N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide
CAS Number:
219311-44-1
Molecular Formula:
C12H16ClN3O3S
Molecular Weight:
317.7917
IUPAC Name:
N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide
InChI:
InChI=1S/C12H16ClN3O3S/c1-8-10(19-7-11-14-5-6-15-11)4-3-9(13)12(8)16-20(2,17)18/h3-4,16H,5-7H2,1-2H3,(H,14,15)
InChI Key:
FOYWMEJSRSBQGB-UHFFFAOYSA-N
SMILES:
Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1
UNII:
LGX4GZ74WO
Properties
Complexity:
463
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
317.06g/mol
Formal Charge:
0
Heavy Atom Count:
20
Hydrogen Bond Acceptor Count:
5
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
317.788g/mol
Monoisotopic Mass:
317.06g/mol
Rotatable Bond Count:
5
Topological Polar Surface Area:
88.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.9
Literature
| Title | Journal |
|---|---|
| Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral function. | The Journal of pharmacology and experimental therapeutics 20090901 |
| A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence. | BJU international 20040601 |
| A randomized crossover study to evaluate Ro 115-1240, a selective alpha-adrenoceptor partial agonist in women with stress urinary incontinence. | BJU international 20040501 |
| A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence. | BJU international 20040101 |
| Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence. | BJU international 20040101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.